Brief: Irlab Therapeutics Q4 Oper Loss Widens To SEK 33.1 Mln

IRLAB Therapeutics AB

23/02/2023 06:12

Feb 23 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * Q4 NET SALES RECORDED: SEK 12.2M (SEK 12.1M)
    * Q4 OPERATING RESULT: SEK -33.1M (SEK -23.1M)

Source text for Eikon:  ID:nMFN2Bsy8C 
Further company coverage:  IRLABa.ST 
 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))